1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

TABLE 2:

Conservative treatment of 29 patients with incomplete central retinal artery occlusion

PentoxifyllinHemodilutionAspirinAcetacolamid (Diamox)Heparin
2* (7.89%)25 (86.2%)4 (13.79%)3 (10.34%)10 (34.48%)
Additional treatment or single treatment
Pentoxifyllin + additional treatment in one patient*Hemodilution + additional treatment in 12 patients9 Heparin + 1 Marcumar)
Pentoxifyllin only in one (3.45%) patientHemodilution only in 11 (39.93%) patientsAspirin only in one (3.45%) patientDiamox only in one (3.45%) patientHeparin only in one (3.45%) patient
  • Note.—In all patients, an immediate massage of the globe and treatment of high blood pressure were performed.

  • * Pentoxifyllin + hemodilution + aspirin, one (3.45%) patient.

  • Hemodilution + heparin, nine (31.03%) patients; hemodilution + aspirin, two (6.89%) patients; hemodilution + Diamox, two (6.89%) patients.